Monthly
US$200
Billed every month
Lidocaine and Prilocaine Cream(利丙双卡因乳膏)
Companies, stages and changes, with each record available on this page.
Last 90 days: Accepted: 9 applications
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Company names, approval identifiers and strengths are retained as recorded in the Chinese sources. Category labels include the original wording for verification.
Catalogue holders0View records ↓
Under-review filings25View records ↓
This year’s generic filers3View records ↓
NHSA approval numbers41View records ↓
API companies with A status0View records ↓
Chemical-drug catalogue
Loaded records: 0 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 0 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | ||||||
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 41 distinct approval numbers and 35 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| 国药集团致君(深圳)坪山制药有限公司 | 国药准字H20254428 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002010100430 | NHSA |
| 江苏吴中医药集团有限公司苏州制药厂 | 国药准字H20265664 | 30g:利多卡因750mg,丙胺卡因750mg | Not stated by source | XN01BBL053F002010101504 | NHSA |
| 苏州二叶制药有限公司 | 国药准字H20253227 | 30g:利多卡因0.75g与丙胺卡因0.75g | Not stated by source | XN01BBL053F002010101651 | NHSA |
| 德全药品(江苏)股份有限公司 | 国药准字H20253274 | 30g:利多卡因750mg,丙胺卡因750mg | Not stated by source | XN01BBL053F002010101751 | NHSA |
| 河北新张药股份有限公司 | 国药准字H20249681 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002010102673 | NHSA |
| 广东科泓药业有限公司 | 国药准字H20253151 | 5g:利多卡因125mg,丙胺卡 因125mg | Not stated by source | XN01BBL053F002010103063 | NHSA |
| 山东明仁福瑞达制药股份有限公司 | 国药准字H20253865 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010104144 | NHSA |
| 山东新华制药股份有限公司 | 国药准字H20255987 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010104187 | NHSA |
| 浙江昂利康制药股份有限公司 | 国药准字H20253006 | 30g:利多卡因750mg,丙胺卡因750mg | Not stated by source | XN01BBL053F002010104606 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20249104 | 1g:利多卡因25mg,丙胺卡因25mg | Not stated by source | XN01BBL053F002010104942 | NHSA |
| 江西施美药业股份有限公司 | 国药准字H20253044 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010105356 | NHSA |
| 海南海灵化学制药有限公司 | 国药准字H20249736 | 10g:利多卡因250mg,丙胺卡因250mg | Not stated by source | XN01BBL053F002010105775 | NHSA |
| 湖南状元制药有限公司 | 国药准字H20254771 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002010105788 | NHSA |
| 上海朝晖药业有限公司 | 国药准字H20255207 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002010106917 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20253362 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010107360 | NHSA |
| 北京中泰邦医药科技有限公司 | 国药准字H20254628 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010110137 | NHSA |
| Aspen Pharmacare Australia Pty Ltd | H20100154 | 1g:利多卡因25mg，丙胺卡因25mg | Not stated by source | XN01BBL053F002010179096 | NHSA |
| 四川海思科制药有限公司 | 国药准字H20233544 | 1g:利多卡因25mg与丙胺卡因25mg | Not stated by source | XN01BBL053F002010179282 | NHSA |
| 福元药业有限公司 | 国药准字H20254749 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002010180651 | NHSA |
| 湖北成田药业有限公司 | 国药准字H20255211 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002010180999 | NHSA |
| 华润双鹤药业股份有限公司 | 国药准字H20255085 | 10g:利多卡因250mg,丙胺卡因250mg | Not stated by source | XN01BBL053F002010181661 | NHSA |
| 浙江普利药业有限公司 | 国药准字H20265498 | 30g:利多卡因750mg,丙胺卡因750mg | Not stated by source | XN01BBL053F002010182922 | NHSA |
| 吉林省金派格药业有限责任公司 | 国药准字H20233629 | 1g: 利多卡因25mg与丙胺卡因25mg | Not stated by source | XN01BBL053F002010183354 | NHSA |
| 南京瑞捷医药科技有限公司 | 国药准字H20265342 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010183421 | NHSA |
| 安徽四环科宝制药有限公司 | 国药准字H20264611 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010183595 | NHSA |
| 景时(杭州)药业有限公司 | 国药准字H20253898 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002010183975 | NHSA |
| 海南紫程众投生物科技有限公司 | 国药准字H20249685 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002010184112 | NHSA |
| 浙江高跖医药科技股份有限公司 | 国药准字H20253877 | 5g:利多卡因 125mg 与丙胺卡因 125mg | Not stated by source | XN01BBL053F002010184221 | NHSA |
| 宁波美舒药业有限公司 | 国药准字H20256240 | 30g:利多卡因750mg,丙胺卡因750mg | Not stated by source | XN01BBL053F002010184223 | NHSA |
| 浙江沣华医药科技有限公司 | 国药准字H20253758 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010184235 | NHSA |
| 浙江寰领医药科技有限公司 | 国药准字H20263664 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010184239 | NHSA |
| 成都天之翼尚品医药科技有限公司 | 国药准字H20253517 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010184759 | NHSA |
| 杭州领业医药科技有限公司 | 国药准字H20249680 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010184874 | NHSA |
| 海南和瑞达药业有限公司 | 国药准字H20249103 | 1g:利多卡因25mg与丙胺卡因25mg | Not stated by source | XN01BBL053F002010185053 | NHSA |
| 渼颜空间(河北)生物科技有限公司 | 国药准字H20249822 | 30g:利多卡因750mg,丙胺卡因750mg | Not stated by source | XN01BBL053F002010185219 | NHSA |
| 河北新张药股份有限公司 | 国药准字H20249681 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002010202673 | NHSA |
| 浙江昂利康制药股份有限公司 | 国药准字H20253006 | 30g:利多卡因750mg,丙胺卡因750mg | Not stated by source | XN01BBL053F002010204606 | NHSA |
| 海南海灵化学制药有限公司 | 国药准字H20249736 | 10g:利多卡因250mg,丙胺卡因250mg | Not stated by source | XN01BBL053F002010205775 | NHSA |
| 上海朝晖药业有限公司 | 国药准字H20255207 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002010206917 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20253362 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010207360 | NHSA |
| 福元药业有限公司 | 国药准字H20254749 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002010280651 | NHSA |
| 浙江高跖医药科技股份有限公司 | 国药准字H20253877 | 5g:利多卡因 125mg 与丙胺卡因 125mg | Not stated by source | XN01BBL053F002010284221 | NHSA |
| 浙江沣华医药科技有限公司 | 国药准字H20253758 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010284235 | NHSA |
| 浙江寰领医药科技有限公司 | 国药准字H20263664 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010284239 | NHSA |
| 杭州领业医药科技有限公司 | 国药准字H20249680 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010284874 | NHSA |
| 浙江昂利康制药股份有限公司 | 国药准字H20253006 | 30g:利多卡因750mg,丙胺卡因750mg | Not stated by source | XN01BBL053F002010304606 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20253362 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010307360 | NHSA |
| 福元药业有限公司 | 国药准字H20254749 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002010380651 | NHSA |
| 浙江高跖医药科技股份有限公司 | 国药准字H20253877 | 5g:利多卡因 125mg 与丙胺卡因 125mg | Not stated by source | XN01BBL053F002010384221 | NHSA |
| 浙江沣华医药科技有限公司 | 国药准字H20253758 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010384235 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20253362 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010407360 | NHSA |
| 福元药业有限公司 | 国药准字H20254749 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002010480651 | NHSA |
| 浙江高跖医药科技股份有限公司 | 国药准字H20253877 | 5g:利多卡因 125mg 与丙胺卡因 125mg | Not stated by source | XN01BBL053F002010484221 | NHSA |
| 浙江沣华医药科技有限公司 | 国药准字H20253758 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010484235 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20253362 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010507360 | NHSA |
| 福元药业有限公司 | 国药准字H20254749 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002010580651 | NHSA |
| 浙江高跖医药科技股份有限公司 | 国药准字H20253877 | 5g:利多卡因 125mg 与丙胺卡因 125mg | Not stated by source | XN01BBL053F002010584221 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20253362 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010607360 | NHSA |
| 福元药业有限公司 | 国药准字H20254749 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002010680651 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20253362 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010707360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20253362 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010807360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20253362 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002010907360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20253362 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002011007360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20253362 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002011107360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20253362 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002011207360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20253362 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002011307360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20253362 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002011407360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20253362 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002011507360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20253362 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002011607360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20253362 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002011707360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20253362 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002011807360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20253362 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002011907360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20253362 | 30g:利多卡因750mg与丙胺卡因750mg | Not stated by source | XN01BBL053F002012007360 | NHSA |
| 河北新张药股份有限公司 | 国药准字H20269044 | 30g:利多卡因750mg与丙胺 卡因750mg | Not stated by source | XN01BBL053F002020102673 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269015 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002020107360 | NHSA |
| 四川海思科制药有限公司 | 国药准字H20233544 | 1g:利多卡因25mg与丙胺卡因25mg | Not stated by source | XN01BBL053F002020179282 | NHSA |
| 吉林省金派格药业有限责任公司 | 国药准字H20233629 | 1g: 利多卡因25mg与丙胺卡因25mg | Not stated by source | XN01BBL053F002020183354 | NHSA |
| 景时(杭州)药业有限公司 | 国药准字H20258294 | 30g:利多卡因750mg与丙胺 卡因750mg | Not stated by source | XN01BBL053F002020183975 | NHSA |
| 成都天之翼尚品医药科技有限公司 | 国药准字H20269191 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002020184759 | NHSA |
| 海南和瑞达药业有限公司 | 国药准字H20249103 | 1g:利多卡因25mg与丙胺卡因25mg | Not stated by source | XN01BBL053F002020185053 | NHSA |
| 渼颜空间(河北)生物科技有限公司 | 国药准字H20269008 | 5g:利多卡因125mg,丙胺卡因125mg | Not stated by source | XN01BBL053F002020185219 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269015 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002020207360 | NHSA |
| 成都天之翼尚品医药科技有限公司 | 国药准字H20269191 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002020284759 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269015 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002020307360 | NHSA |
| 成都天之翼尚品医药科技有限公司 | 国药准字H20269191 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002020384759 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269015 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002020407360 | NHSA |
| 成都天之翼尚品医药科技有限公司 | 国药准字H20269191 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002020484759 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269015 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002020507360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269015 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002020607360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269015 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002020707360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269015 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002020807360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269015 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002020907360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269015 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002021007360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269015 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002021107360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269015 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002021207360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269015 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002021307360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269015 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002021407360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269015 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002021507360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269015 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002021607360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269015 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002021707360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269015 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002021807360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269015 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002021907360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269015 | 5g:利多卡因125mg与丙胺卡因125mg | Not stated by source | XN01BBL053F002022007360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269016 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002030107360 | NHSA |
| 四川海思科制药有限公司 | 国药准字H20233544 | 1g:利多卡因25mg与丙胺卡因25mg | Not stated by source | XN01BBL053F002030179282 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269016 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002030207360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269016 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002030307360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269016 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002030407360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269016 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002030507360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269016 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002030607360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269016 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002030707360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269016 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002030807360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269016 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002030907360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269016 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002031007360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269016 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002031107360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269016 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002031207360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269016 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002031307360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269016 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002031407360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269016 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002031507360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269016 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002031607360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269016 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002031707360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269016 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002031807360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269016 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002031907360 | NHSA |
| 广州朗圣药业有限公司 | 国药准字H20269016 | 10g:利多卡因250mg与丙胺卡因250mg | Not stated by source | XN01BBL053F002032007360 | NHSA |
| 四川海思科制药有限公司 | 国药准字H20233544 | 1g:利多卡因25mg与丙胺卡因25mg | Not stated by source | XN01BBL053F002040179282 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 25 filings and 16 distinct first applicants.
Generic 11 · Supplement 14
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 吉林省奇健生物技术有限公司;药源生物科技（启东）有限公司 | CYHS2502722 | Generic | 2025/07/30 | Not stated by source | CDE |
| 北京中泰邦医药科技有限公司;江苏盈科生物制药有限公司 | CYHB2601490 | Supplement | 2026/08/04 | Not stated by source | CDE |
| 江苏盈科生物制药有限公司 | CYHB2501640 | Supplement | 2025/08/19 | Not stated by source | CDE |
| 德全药品（江苏）股份有限公司 | CYHB2601334 | Supplement | 2026/07/14 | Not stated by source | CDE |
| 德全药品（江苏）股份有限公司 | CYHB2501935 | Supplement | 2025/09/29 | Not stated by source | CDE |
| 浙江昂利康制药股份有限公司 | CYHB2601917 | Supplement | 2026/10/21 | Not stated by source | CDE |
| 杭州领业医药科技有限公司 | CYHB2601716 | Supplement | 2026/09/10 | Not stated by source | CDE |
| 杭州领业医药科技有限公司 | CYHB2601715 | Supplement | 2026/09/10 | Not stated by source | CDE |
| 杭州领业医药科技有限公司 | CYHB2601714 | Supplement | 2026/09/10 | Not stated by source | CDE |
| 海南和瑞达药业有限公司;浙江赛默制药有限公司 | CYHB2601198 | Supplement | 2026/06/26 | Not stated by source | CDE |
| 重庆康刻尔制药股份有限公司;山东诺禾康药业有限公司 | CYHS2601330 | Generic | 2026/06/08 | Not stated by source | CDE |
| 湖南九典制药股份有限公司 | CYHB2601048 | Supplement | 2026/06/04 | Not stated by source | CDE |
| 湖南九典制药股份有限公司 | CYHB2601047 | Supplement | 2026/06/04 | Not stated by source | CDE |
| 国大（吉林）制药集团有限公司;南昌立健药业有限公司 | CYHS2600718 | Generic | 2026/03/26 | Not stated by source | CDE |
| 深圳市宇健生物医药有限公司;深圳市新阳唯康科技有限公司 | CYHS2504321 | Generic | 2025/12/19 | Not stated by source | CDE |
| 深圳市宇健生物医药有限公司;深圳市新阳唯康科技有限公司 | CYHS2504320 | Generic | 2025/12/19 | Not stated by source | CDE |
| 深圳市宇健生物医药有限公司;深圳市新阳唯康科技有限公司 | CYHS2504319 | Generic | 2025/12/19 | Not stated by source | CDE |
| 海南海神同洲制药有限公司 | CYHS2504234 | Generic | 2025/12/10 | Not stated by source | CDE |
| 河北华晨药业集团有限公司 | CYHS2502695 | Generic | 2025/07/25 | Not stated by source | CDE |
| 河北华晨药业集团有限公司 | CYHS2502694 | Generic | 2025/07/25 | Not stated by source | CDE |
| 广东泰恩康制药厂有限公司 | CYHS2501621 | Generic | 2025/04/30 | Not stated by source | CDE |
| 哈药集团生物工程有限公司 | CYHS2602610 | Generic | 2026/10/23 | Not stated by source | CDE |
| 广州朗圣药业有限公司 | CYHB2601983 | Supplement | 2026/10/29 | Not stated by source | CDE |
| 广州朗圣药业有限公司 | CYHB2601982 | Supplement | 2026/10/29 | Not stated by source | CDE |
| 广州朗圣药业有限公司 | CYHB2601981 | Supplement | 2026/10/29 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 3 filings and 3 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 重庆康刻尔制药股份有限公司;山东诺禾康药业有限公司 | CYHS2601330 | Generic | 2026/06/08 | Not stated by source | CDE |
| 国大（吉林）制药集团有限公司;南昌立健药业有限公司 | CYHS2600718 | Generic | 2026/03/26 | Not stated by source | CDE |
| 哈药集团生物工程有限公司 | CYHS2602610 | Generic | 2026/10/23 | Not stated by source | CDE |
API registrations
Non-component matches: 0 companies with A status and 0 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | ||||||
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/10 07:23. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
-
2026/10/29Accepted
-
2026/10/29Accepted
-
2026/10/29Accepted
-
2026/10/23Accepted
-
2026/10/21Accepted
-
2026/09/11Accepted
乐福思健康产业股份公司;药源生物科技（启东）有限公司
CYHB2601728
Fact date: 2026/09/11 · Site observation date: 2026/10/21
View source ↗ -
2026/09/10Accepted
-
2026/09/10Accepted
-
2026/09/10Accepted
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/10 07:27
- Chemical-drug catalogue
- Last successful update: 2026/11/10 07:23
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/10 07:25
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31
First index-page publication dates: 2026-10-26 to 2026-11-10; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/10 08:10 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 3/30; discovered pending details: 20. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Lidocaine and Prilocaine Cream
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Yearly
US$1,920
Billed every year
US$160 per month
Online subscriptions are not enabled. The form below registers interest; it does not charge or activate access.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
US$490
One payment · 12 months of access
Online comparison-table purchase is not enabled.
Billed by Creem, our merchant of record · Terms · Refund policy